ApprovalTrail

Approval · Notice of Compliance 37285 · 2026

SIMPONI: Notice of Compliance 37285

Issued April 7, 2026

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
37285
Date
April 7, 2026
Company
Janssen Inc.Toronto, Ontario, Canada
Product type
Biologic
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Product Monograph update

Products in this notice

BrandDINStatus today
SIMPONINot yet assigned—
SIMPONI I.V.Not yet assigned—

Medicinal ingredients